Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer

Annals of Oncology

Volumn 9, Issue 2, 1998, Pages 181-185

  Pasini, F ^a,d   Pelosi, G ^c   Verlato, G ^a   Guidi, G ^a   Pavanel, F ^a   Tummarello, D ^b   Masotti, A ^c   Cetto, G L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d Cattedra di Oncologia Medica   (Italy)

Author keywords

Bone marrow; Monoclonal antibodies; Small cell lung cancer; Survival; Tumor markers

Indexed keywords

ALKALINE PHOSPHATASE; CARCINOEMBRYONIC ANTIGEN; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; NEURON SPECIFIC ENOLASE; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; TUMOR CELL;

EID: 0031939342     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008226025229     Document Type: Article

References (34)

1. Souhami RL, Beverly PCL, Bobrow LG. Antigens of small-cell lung cancer. Lancet 1987; 8 August: 325-6.
2. Souhami RL, Beverly PCL, Bobrow LG et al. Antigens of lung cancer: results of the second International Workshop on Lung Cancer Antigens (Commentary). J Natl Cancer Inst 1991; 83 (9): 609-12.
3. Stahel RA, Gilks WR, Lehmann H et al. Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis. Int J. Cancer 1994; 8 (Suppl): 6-26.
4. Agresti R, Alzani R, Andreola S et al. Histopathological characterisation of a novel monoclonal antibody, MLuC1, reacting with lung carcinomas. Tumori 1988; 74: 401-10.
5. Ripamonti M, Canevari S, Ménard S et al. Human carcinoma cell lines xenografted in athymic mice: Biological and antigenic characteristics of an intra-abdominal model. Cancer Immunol Immunother 1987; 24: 13-8.
6. y are preferentially expressed on small cell lung cancer cells as detected by the monoclonal antibody MLuC1. Int J Cancer 1992; 51:225-31.
7. Ménard S, Porrow G, Giani S et al. Detection of SCLC metastatic cells in bone marrow by means of the monoclonal antibody MLuC1. Lung Cancer 1988; 4: 73-5.
8. Myklebust AT, Beiske K, Pharo A et al. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. B J Cancer 1991; 63 (Suppl XIV): 49-53.
9. Beiske K, Myklebust T, Aamdal S et al. Detection of bone marrow metastasis in small cell lung cancer patients. Am J Pathol 1992, 141: 531-8.
10. Derbyshire EJ, Ménard S, Wawrzynczak EJ. Cytotoxic activity of MLuC1-ricin A chain recognizing the Y hapten associated with human small cell lung carcinoma. Fund Clin Immunol 1993; 119-26.
11. Pasini F, Pelosi G, Ledermann JA et al. Detection of small cell lung cancer in bone-marrow aspirates by monclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1. Int J Cancer 1994; 8 (Suppl): 53-6.
12. Pelosi G, Molino A, Turazza M et al. Immunodetection of breast cancer cells in bone marrow for monitoring high-dose sequential chemotherapy. Appl Immunonohistochem 1997; 5(1): 67-70.
13. Campos-Filho N, Franco EL. Microcomputer-assisted univariated survival data analysis using Kaplan-Meier life table estimators. Comp Meth Prog Biomed 1988; 27: 223-8.
14. Norusis MJ. SPSS Advanced Statistics 6.1. (1994). SPSS Inc.: Chicago, IL.
15. Stahel RA, Mabry M, Skarin AT et al. Detection of bone marrow metastasis in small cell lung cancer by monoclonal antibody. J Clin Oncol 1985; 3: 455-61.
16. Berendsen HH, De Leij L, Postmus PE et al. Detection of small cell lung cancer metastasis in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentation antigen. J Clin Pathol 1988; 41: 273-6.
17. Molino A, Colombatti M, Bonetti F et al. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 1991; 67: 1033-6.
18. Hirsch FR, Hansen HH. Bone marrow involvement in small cell anaplastic carcinoma of the lung. Prognostic and therapeutic aspects. Cancer 1980; 46: 206-11.
19. Kelly BW, Morris JF, Harwood BP et al. Methods and prognostic value of bone marrow examination in small cell carcinoma of the lung. Cancer 1984; 53: 99-102.
20. Leonard RCF, Duncan LW, Hay FO. Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res 1990; 50: 6545-8.
21. Pasini F, Pelosi G , Mostacci R et al. Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations. Ann Oncol 1995; 6: 86-8.
22. James LE, Gower NH, Rudd RM et al. A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor prognosis small-cell lung cancer: A Cancer Research Campaign trial. Br J Cancer 1996; 73: 1563-8.
23. Brugger W, Bross K, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83, 3: 636-40.
24. Myklebust AT, Pharo A, Fodstad ø. Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads. Br J Cancer 1993; 67: 1331-6.
25. Trail PA, Willner D, Lash SJ et al. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models. Cancer Res 1993; 52: 5693-700.
26. Gronowitz J, Bergström R, Nôu E et al. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis. Cancer 1990; 66: 722-32.
27. Jargensen LGM, Osterlind K, Genollà J et al. Serum neuronspecific enolase (NSE) and the prognosis in small cell lung cancer (SCLC). A combined multivariate analysis on data from nine centres. Br J Cancer 1996; 74: 463-567.
28. Sagman U, Feld R, Evans WK et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small cell lung cancer. J Clin Oncol 1991; 9 (6): 954-61.
29. Lassen U, Østerlind K, Hansen M et al. Long-term survival in small-cell lung cancer: Posttreatment characteristics in patients surviving 5 to 18+ years. An analysis of 1,714 consecutive patients. J Clin Oncol 1995; 13: 1215-20.
30. Van der Gaast A, Van Putten WLJ, Oosterom R et al. Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer. Br J Cancer 1991; 64: 369-72.
31. Østerlind K, Hirsch FR, Pedersen AG. Serum lactate dehydrogenase and bone marrow metastases in small cell lung cancer of the lung (Letter). N Engl J Med 1985; 313 (12): 759-60.
32. Doll DC. Serum lactate dehydrogenase and bone marrow involvement in small cell lung cancer of the lung (Letter). N Engl J Med 1985; 312(19): 1262.
33. Johnson DH, Greco AF. Serum lactate dehydrogenase and bone marrow metastases in small cell lung cancer of the lung (Letter). N Engl J Med 1985; 313(12): 759-60.
34. Bucher M, Manegold C, Krempien B et al. Immunocytological staining with HEA-125 on bone marrow aspirates for staging small cell lung cancer (SCLC). Ann Oncol 1994; 5 (Suppl 8): P820 (Abstr), 163.